MiMedx Group Inc (MDXG)
7.235
+0.04
(+0.49%)
USD |
NASDAQ |
May 09, 15:31
MiMedx Group Market Cap: 1.068B for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 1.063B |
| May 07, 2024 | 1.076B |
| May 06, 2024 | 1.052B |
| May 03, 2024 | 1.088B |
| May 02, 2024 | 1.107B |
| May 01, 2024 | 1.079B |
| April 30, 2024 | 909.24M |
| April 29, 2024 | 924.00M |
| April 26, 2024 | 925.48M |
| April 25, 2024 | 921.79M |
| April 24, 2024 | 949.09M |
| April 23, 2024 | 960.77M |
| April 22, 2024 | 938.63M |
| April 19, 2024 | 928.30M |
| April 18, 2024 | 909.11M |
| April 17, 2024 | 934.20M |
| April 16, 2024 | 919.44M |
| April 15, 2024 | 937.15M |
| April 12, 2024 | 950.44M |
| April 11, 2024 | 975.52M |
| April 10, 2024 | 966.67M |
| April 09, 2024 | 1.036B |
| April 08, 2024 | 1.018B |
| April 05, 2024 | 1.033B |
| April 04, 2024 | 1.036B |
| Date | Value |
|---|---|
| April 03, 2024 | 1.034B |
| April 02, 2024 | 1.015B |
| April 01, 2024 | 1.099B |
| March 28, 2024 | 1.132B |
| March 27, 2024 | 1.118B |
| March 26, 2024 | 1.120B |
| March 25, 2024 | 1.151B |
| March 22, 2024 | 1.182B |
| March 21, 2024 | 1.199B |
| March 20, 2024 | 1.205B |
| March 19, 2024 | 1.183B |
| March 18, 2024 | 1.158B |
| March 15, 2024 | 1.158B |
| March 14, 2024 | 1.146B |
| March 13, 2024 | 1.168B |
| March 12, 2024 | 1.174B |
| March 11, 2024 | 1.176B |
| March 08, 2024 | 1.199B |
| March 07, 2024 | 1.198B |
| March 06, 2024 | 1.186B |
| March 05, 2024 | 1.176B |
| March 04, 2024 | 1.214B |
| March 01, 2024 | 1.268B |
| February 29, 2024 | 1.199B |
| February 28, 2024 | 1.205B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
298.95M
Minimum
Dec 19 2022
1.772B
Maximum
Sep 08 2021
724.23M
Average
673.92M
Median
Market Cap Benchmarks
| TELA Bio Inc | 125.73M |
| Amylyx Pharmaceuticals Inc | 125.06M |
| CEL-SCI Corp | 81.51M |
| AIM ImmunoTech Inc | 21.96M |
| IGC Pharma Inc | 34.10M |
Market Cap Related Metrics
| PE Ratio | 14.47 |
| PS Ratio | 2.874 |
| Price to Book Value | 6.857 |
| Price to Free Cash Flow | 32.80 |
| Price | 7.235 |
| Earnings Yield | 6.91% |
| Operating PE Ratio | 17.89 |
| Normalized PE Ratio | 14.32 |